MARKET

AMRS

AMRS

Amyris
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.242
+0.012
+0.28%
Opening 10:02 01/27 EST
OPEN
4.350
PREV CLOSE
4.230
HIGH
4.430
LOW
4.229
VOLUME
724.51K
TURNOVER
--
52 WEEK HIGH
23.42
52 WEEK LOW
3.880
MARKET CAP
1.31B
P/E (TTM)
-2.8516
1D
5D
1M
3M
1Y
5Y
BRIEF-Amyris Announces Appointment Of Ana Dutra To Board
reuters.com · 1h ago
Amyris, Inc. (AMRS) Gains As Market Dips: What You Should Know
In the latest trading session, Amyris, Inc. (AMRS) closed at $4.23, marking a +0.48% move from the previous day.
Zacks · 15h ago
Turquoise Hill leads Energy/Material gainers; NextEra Energy and Amyris among losers
Gainers: Turquoise Hill Resources (NYSE:TRQ) +15%. Nine Energy Service (NYSE:NINE) +14%. GoldMining (NYSE:GLDG) +13%. Snow Lake Resources (NASDAQ:LITM) +12%. Kosmos Energy (NYSE:KOS) +11%. Losers: Equitrans Midstream (NYSE:ETRN) -14%. Vertex Energy (NASDAQ...
Seekingalpha · 1d ago
Amyris and Alto Ingredients among Energy/Material gainers; Origin Agritech among losers
Gainers: Exterran (NYSE:EXTN) +58%. Uranium Royalty (NASDAQ:UROY) +8%. Amyris (NASDAQ:AMRS) +7%. Alto Ingredients (NASDAQ:ALTO) +8%. Mesabi (NYSE:MSB) +6%. Losers: ReTo Eco-Solutions (NASDAQ:RETO) -55%. Indonesia Energy Corporation (NYSE:INDO) -13%. Eco Wa...
Seekingalpha · 2d ago
BRIEF-Amyris To Acquire Menolabs For Menopause Wellness Accelerating Growth Of Consumer Business
reuters.com · 3d ago
Amyris to acquire women's wellness company, MenoLabs
Amyris (NASDAQ:AMRS) has agreed to exclusive terms to acquire the assets of MenoLabs, LLC, a growing women's wellness brand focused on addressing perimenopause and menopause symptoms. Amyris previously communicated its
Seekingalpha · 3d ago
Amyris To Acquire MenoLabs; Terms Not Disclosed
Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform announces that it has
Benzinga · 3d ago
Amyris to Buy MenoLabs
MT Newswires · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMRS. Analyze the recent business situations of Amyris through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

33.33%Strong Buy
66.67%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AMRS stock price target is 19.50 with a high estimate of 30.00 and a low estimate of 12.00.
High30.00
Average19.50
Low12.00
Current 4.242
EPS
Actual
Estimate
-0.85-0.62-0.39-0.17
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 248
Institutional Holdings: 122.66M
% Owned: 39.79%
Shares Outstanding: 308.24M
TypeInstitutionsShares
Increased
76
6.21M
New
58
3.22M
Decreased
43
5.67M
Sold Out
36
16.26M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Commodity Chemicals
+1.56%
Chemicals
+1.58%
Key Executives
Non-Executive Chairman/Independent Director
Geoffrey Duyk
Chief Executive Officer/President/Director
John Melo
Chief Financial Officer/Chief Administrative Officer
Han Kieftenbeld
Chief Operating Officer
Eduardo Alvarez
General Counsel/Secretary
Nicole Kelsey
Other
Francisco Costa
Director
Philip Eykerman
Director
Ryan Panchadsaram
Independent Director
John Doerr
Independent Director
Frank Kung
Independent Director
James Mccann
Independent Director
Steven Mills
Independent Director
Lisa Qi
Independent Director
Julie Washington
No Data
About AMRS
Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance.

Webull offers kinds of Amyris Inc stock information, including NASDAQ:AMRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRS stock methods without spending real money on the virtual paper trading platform.